GCG and Insulin resistance: When looking into insulin secretion and insulin resistance (Figure 2, panels B and C), genetic variation in the targets of sulfonylureas and GLP-1 analogues was associated with increased insulin secretion, whereas insulin/insulin analogues and TZD were associated with decreased insulin resistance, consistent with the drug mechanism of actions.